Basal cell carcinoma MRI: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 2: | Line 2: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{M.N}} | ||
==Overview== | ==Overview== | ||
| Line 29: | Line 29: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category: | [[Category:Oncology]] | ||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category: | [[Category:Surgery]] | ||
[[Category: | [[Category:Radiology]] | ||
Latest revision as of 15:19, 6 March 2019
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma MRI On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma MRI |
|
Risk calculators and risk factors for Basal cell carcinoma MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
MRI is useful when the tumor has any adjacent bony or perineural invasion. On T1- it appears as an enhancing isointense lesion. On T2- it appears as an hyperintense lesion.
MRI
- Basal cell carcinoma is usually diagnosed based on history and physical examination
- MRI is useful when the tumor has any adjacent bony or perineural invasion[1]
- On T1- it appears as an enhancing isointense lesion
- On T2- it appears as an hyperintense lesion
References
- ↑ Baheti AD, Tirumani SH, Giardino A, Rosenthal MH, Tirumani H, Krajewski K, Ramaiya NH (February 2015). "Basal cell carcinoma: a comprehensive review for the radiologist". AJR Am J Roentgenol. 204 (2): W132–40. doi:10.2214/AJR.14.13160. PMID 25615773.
Template:Tumors of bone, cartilage, skin, connective, and soft tissue